The Covid-19 pandemic has accelerated the need for remote care and patient monitoring, which exceeds the four walls of healthcare providers. In a webinar on remote monitoring of chronic diseases, the conversation will explore how OmniSense, a medical device manufacturer in the field of home health tracking, uses BioT’s connected care platform to support home care and remote patient monitoring. The combined system enables patients to establish contact with nursing staff by enhancing telemedicine calls, detecting warning signals early, triggering timely intervention, and reducing hospitalization needs.
The webinar is scheduled for July 21, 1:00 p.m. EST.
In this webinar, you will learn about:
- How the IoMT platform enables healthcare providers, caregivers and medical technology companies to provide personalized and complete continuous care, even at home, to extend and improve the quality of life
- With the help of the connected care platform, how can caregivers and medical device companies optimize their resources and work processes, gain meaningful insights from direct contact with patients, and introduce new business models
- How OmnySense and BioT launched a regulated home care medical monitoring platform that enables caregivers and healthcare providers to treat patients remotely
OmnySense is developing a multi-parameter medical device for home inspection, seamlessly integrated into OmnySense’s cloud-based remote health tracking system, supported by BioT.
BioT is an easy-to-integrate cloud-based platform designed to instantly connect medical devices, patients, caregivers and data to ensure seamless and continuous care.
The webinar speakers are:
Daniel Adler, CEO and co-founder of BioT
Daniel has more than 20 years of rich experience in the IT and IoT fields, and now uses his deep understanding of connectivity to build cloud solutions for medical IoT devices.As the CEO of BioT, he manages the development team Provide cloud-based connectivity and interconnected care solutions for medical equipment and pharmaceutical companies.
Previously, he managed the automotive business unit at Valens, a leading semiconductor company in the high-speed connectivity field. Prior to joining Valens, Daniel was the Vice President of Sales and Business Development for 3i-MIND. He also served as the business development and strategic account director of NICE Systems (code: NICE), responsible for key global accounts. Daniel holds a Bachelor of Science degree. Majored in Computer Science from Israel Institute of Technology.
Ian Solomon, co-founder and CTO of OmnySense
Ian is a serial entrepreneur in the field of medical devices and drug delivery. Before co-founding OmnySense, he co-founded TimeStamp, which developed a connectivity solution for monitoring medication compliance, especially for inhalers. Previously, he was the co-founder of SteadyMed, an electronic patch pump company, which was sold to United Therapeutics for US$216 million.
Before setting foot in the medical field, Ian worked in the field of information systems and communications for more than 20 years, holding a series of technical and marketing positions. Ian holds a Bachelor of Science degree. PhD in Physics, University of Sussex, UK.
To participate in the webinar, please fill out the form below:
By filling out this form, you have chosen to receive communications from MedCity News and its partners.
photo: chombosan, Getty Images
